This announcement is a separate document:
百普赛斯：上海市通力律师事务所关于北京百普赛斯生物科技股份有限公司2023年限制性股票激励计划的法律意见书
Bopsis: Legal Opinion of Shanghai Tongli Law Firm on Beijing Biopsis Biotechnology Co., Ltd.\'s 2023 Restricted Stock Incentive Plan
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.